MSD Pharmaceuticals launches first gender-neutral HPV vaccine

INDIA – MSD Pharmaceuticals Pvt. Ltd. has announced the launch of Gardasil 9, India’s first gender-neutral human papillomavirus (HPV) vaccine that will help reduce disease burden and cancers caused by the HPV types among Indian girls, boys and women. Launching 9-valent HPV vaccine (GARDASIL 9) is a crucial step towards building a healthy young generation by reducing the disease burden of HPV-related cancers and diseases. GARDASIL 9 is a nano valent vaccine given intramuscularly in a three-dose regimen spread over 6 months. Cervical cancer is the second most common cancer…

Read More